| Dec 05 | Dec 04 | Dec 03 | Dec 02 | Dec 01 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ -69.39K | $ -318.16K | $ 315.95K | $ 1.15M | - |
| Operating Income | $ -4.74M | $ -6.29M | $ -2.29M | $ -1.88M | $ -2.73M |
| EBITDA | $ -4.59M | $ -6.09M | $ -2.20M | $ -1.74M | $ -2.40M |
| Net Income | $ -4.89M | $ -6.42M | $ -2.28M | $ -1.85M | $ -3.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 1.60M | $ 1.02M | $ 1.69M | $ 2.62M | $ 2.16M |
| Total Debt | $ 23.45K | $ 0.00 | $ 0.00 | $ 0.00 | $ 1.49M |
| Net Debt | $ 22.12K | $ -8.76K | $ -17.32K | $ -243.75K | $ 824.43K |
| Total Liabilities | $ 1.01M | $ 4.72M | $ 610.45K | $ 2.91M | $ 2.35M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -4.91M | $ -4.04M | $ -1.75M | $ -2.42M | $ -1.21M |
| Operating Cash Flow | $ -4.67M | $ -3.95M | $ -1.64M | $ -2.24M | $ -1.20M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Vasamed Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.